Delta Radiomics Model Predicts Lesion-Level Responses to Tyrosine Kinase Inhibitors in Patients with Advanced Renal Cell Carcinoma: A Preliminary Result

Article Oncology

Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry

Margaret F. Meagher et al.

Summary: The role of surgery and metastasectomy in metastatic Renal Cell Carcinoma is undergoing changes. A multicenter comparison study found that metastasectomy was associated with improved survival rates in favorable- and intermediate-risk patients, but not in high-risk patients. These findings suggest the need for refined selection criteria for metastasectomy.

CLINICAL GENITOURINARY CANCER (2022)

添加到收藏夹

Article Oncology

Clinical-radiomic model in advanced kidney cancer predicts response to tyrosine kinase inhibitors

Adrian A. Negreros-Osuna et al.

Summary: This study developed models based on radiomics and clinical data to predict treatment response in patients with advanced kidney cancer treated with TKIs. The results showed that the combined model based on clinical data and radiomics could accurately predict the treatment response in patients.

ONCOLOGY LETTERS (2022)

添加到收藏夹

Review Respiratory System

Pulmonary metastasectomy in renal cell carcinoma: a mainstay of multidisciplinary treatment

Joseph Seitlinger et al.

Summary: The review highlighted the benefits of pulmonary metastasectomy in RCC patients and the role of different treatment modalities, emphasizing the effectiveness in certain circumstances. The IMDC risk model helps identify the best systemic treatment, and with the development of targeted therapies, there are multiple treatment options available.

JOURNAL OF THORACIC DISEASE (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging